Literature DB >> 7906718

Primary structure of the precursor for the anthozoan neuropeptide antho-RFamide from Renilla köllikeri: evidence for unusual processing enzymes.

R K Reinscheid1, C J Grimmelikhuijzen.   

Abstract

Neuropeptides containing the C-terminal sequence Arg-Phe-NH2 are an important group of hormones mediating or modulating neuronal communication. Arg-Phe-NH2 peptides are abundant in evolutionarily "old" nervous systems such as those of coelenterates, the lowest animal group having a nervous system. Here, we have cloned the precursor protein for the anthozoan neuropeptide Antho-RFamide (< Glu-Gly-Arg-Phe-NH2) from the sea pansy Renilla köllikeri. This precursor contains 36 copies of immature Antho-RFamide (Gln-Gly-Arg-Phe-Gly) and two additional putative neuropeptide sequences, which are regularly distributed over the precursor protein. Of the 36 Antho-RFamide sequences, 29 copies are separated by the five amino acid spacer sequence Arg-Glu/Gly-Asn/Ser/Asp-Glu/Lys-Glu. This implicates processing at single Arg and single Glu residues. Endoproteolytic cleavage at the C-terminal side of paired or single basic residues is a well known initial step in the maturation of precursor proteins. Cleavage at the C-terminal side of acidic residues, however, is unusual and must be catalyzed by a new type of processing enzyme. This processing enzyme is most likely to be an endoprotease, because the simplest way to generate Antho-RFamide is by endoproteolytic cleavage at the C-terminal side of Glu residues. The enzyme could also be an aminopeptidase, but in this case other proteases must be involved. As a possible alternative, one single "unspecific" aminopeptidase could cleave at Glu, Asp, Gly, Asn, Ser, and possibly also at other residues, and thus liberate all Antho-RFamide sequences. The processing of one precursor molecule probably yields 38 neuropeptides.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906718     DOI: 10.1046/j.1471-4159.1994.62031214.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  A statistical view of FMRFamide neuropeptide diversity.

Authors:  E Espinoza; M Carrigan; S G Thomas; G Shaw; A S Edison
Journal:  Mol Neurobiol       Date:  2000 Feb-Apr       Impact factor: 5.590

2.  Three different prohormones yield a variety of Hydra-RFamide (Arg-Phe-NH2) neuropeptides in Hydra magnipapillata.

Authors:  D Darmer; F Hauser; H P Nothacker; T C Bosch; M Williamson; C J Grimmelikhuijzen
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods.

Authors:  Rainer K Reinscheid
Journal:  Peptides       Date:  2007-01-20       Impact factor: 3.750

4.  Molecular cloning of a preprohormone from sea anemones containing numerous copies of a metamorphosis-inducing neuropeptide: a likely role for dipeptidyl aminopeptidase in neuropeptide precursor processing.

Authors:  I Leviev; C J Grimmelikhuijzen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Molecular cloning and functional expression of the first insect FMRFamide receptor.

Authors:  Giuseppe Cazzamali; Cornelis J P Grimmelikhuijzen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

Review 6.  Insight into the molecular and functional diversity of cnidarian neuropeptides.

Authors:  Toshio Takahashi; Noriyo Takeda
Journal:  Int J Mol Sci       Date:  2015-01-23       Impact factor: 5.923

Review 7.  Comparative Aspects of Structure and Function of Cnidarian Neuropeptides.

Authors:  Toshio Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-27       Impact factor: 5.555

8.  A combined strategy of neuropeptide prediction and tandem mass spectrometry identifies evolutionarily conserved ancient neuropeptides in the sea anemone Nematostella vectensis.

Authors:  Eisuke Hayakawa; Hiroshi Watanabe; Gerben Menschaert; Thomas W Holstein; Geert Baggerman; Liliane Schoofs
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.